QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (37) Citing Articles via Google Scholar Google Scholar Articles by Siao, C.-J. Articles by Tsirka, S. E. Search for Related Content PubMed PubMed Citation Articles by Siao, C.-J. Articles by Tsirka, S. E.

 Previous Article  |  Next Article 

The Journal of Neuroscience, April 15, 2003, 23(8):3234

Cell Type-Specific Roles for Tissue Plasminogen Activator Released by Neurons or Microglia after Excitotoxic Injury

Chia-Jen Siao¹, Susana R. Fernandez², and Stella E. Tsirka^{1, 2}

¹ Department of Pharmacological Sciences, Program in Molecular and Cellular Pharmacology, and ² Program in Molecular and Cellular Biology, University Medical Center at Stony Brook, Stony Brook, New York 11794-8651

Tissue plasminogen activator (tPA) plays important roles in the brain after excitotoxic injury. It is released by both neurons and microglia and mediates neuronal death and microglial activation. Mice lacking tPA are resistant to excitotoxicity and show very limited microglial activation. Activated microglia are neurotoxic in culture, but this phenomenon is not well documented in vivo. To further understand the sequence of events through which tPA mediates microglial activation and neurodegeneration, we have generated mice that exhibit restricted expression of tPA through introduction of tPA transgenes under the control of neuronal- or microglial-specific promoters into tPA-deficient mice. Neither strain of transgenic mice shows abnormal brain morphology or inflammation in the absence of injury, and unilateral intrahippocampal kainate injections into the transgenic mice induced excitotoxicity and microglial activation reminiscent of wild-type mice. However, there are differences in the kinetics of the resulting pathology. The neuronal tPA-expressing mice exhibit accelerated microglial activation compared with wild-type or microglial tPA-expressing mice. However, microglial tPA-expressing mice exhibit greater neurodegeneration. These data suggest a model in which tPA plays different roles after kainate injection depending on whether it is released by neurons or microglia. We propose that tPA, initially secreted from injured neurons, acts as a cytokine to activate microglia at the site of injury. These activated microglia then secrete additional tPA, which promotes extracellular matrix degradation, neurodegeneration, and self-proliferation. We suggest that an approach to attenuate microglia-mediated neuronal death in vivo might be to pharmacologically prevent microglial activation.

Key words: cell-cell interactions; microglial activation; transgenic mice; hippocampus; neurodegeneration; in vivo

---

Copyright © 2003 Society for Neuroscience  0270-6474/03/2383234-09$05.00/0

This article has been cited by other articles:

				C. Zhang, J. An, D. K. Strickland, and M. Yepes The Low-Density Lipoprotein Receptor-Related Protein 1 Mediates Tissue-Type Plasminogen Activator-Induced Microglial Activation in the Ischemic Brain Am. J. Pathol., February 1, 2009; 174(2): 586 - 594. [Abstract] [Full Text] [PDF]

				A. Reijerkerk, G. Kooij, S. M. A. van der Pol, T. Leyen, B. van het Hof, P.-O. Couraud, D. Vivien, C. D. Dijkstra, and H. E. de Vries Tissue-Type Plasminogen Activator Is a Regulator of Monocyte Diapedesis through the Brain Endothelial Barrier J. Immunol., September 1, 2008; 181(5): 3567 - 3574. [Abstract] [Full Text] [PDF]

				S. R. Parathath, I. Gravanis, and S. E. Tsirka Nitric Oxide Synthase Isoforms Undertake Unique Roles During Excitotoxicity Stroke, June 1, 2007; 38(6): 1938 - 1945. [Abstract] [Full Text] [PDF]

				R. A. Adams, J. Bauer, M. J. Flick, S. L. Sikorski, T. Nuriel, H. Lassmann, J. L. Degen, and K. Akassoglou The fibrin-derived {gamma}377-395 peptide inhibits microglia activation and suppresses relapsing paralysis in central nervous system autoimmune disease J. Exp. Med., March 19, 2007; 204(3): 571 - 582. [Abstract] [Full Text] [PDF]

				T. Nagai, M. Ito, N. Nakamichi, H. Mizoguchi, H. Kamei, A. Fukakusa, T. Nabeshima, K. Takuma, and K. Yamada The Rewards of Nicotine: Regulation by Tissue Plasminogen Activator-Plasmin System through Protease Activated Receptor-1. J. Neurosci., November 22, 2006; 26(47): 12374 - 12383. [Abstract] [Full Text] [PDF]

				J. Chen, Y. Zhou, S. Mueller-Steiner, L.-F. Chen, H. Kwon, S. Yi, L. Mucke, and L. Gan SIRT1 Protects against Microglia-dependent Amyloid-{beta} Toxicity through Inhibiting NF-{kappa}B Signaling J. Biol. Chem., December 2, 2005; 280(48): 40364 - 40374. [Abstract] [Full Text] [PDF]

				K. Benchenane, V. Berezowski, M. Fernandez-Monreal, J. Brillault, S. Valable, M.-P. Dehouck, R. Cecchelli, D. Vivien, O. Touzani, and C. Ali Oxygen Glucose Deprivation Switches the Transport of tPA Across the Blood-Brain Barrier From an LRP-Dependent to an Increased LRP-Independent Process Stroke, May 1, 2005; 36(5): 1059 - 1064. [Abstract] [Full Text] [PDF]

				C. Y. Shin, M. Kundel, and D. G. Wells Rapid, Activity-Induced Increase in Tissue Plasminogen Activator Is Mediated by Metabotropic Glutamate Receptor-Dependent mRNA Translation J. Neurosci., October 20, 2004; 24(42): 9425 - 9433. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help